kongre.net
Welcome to kongre.net
EA
CourseIn person

ESMO Advanced Course on HR+/HER2- Metastatic Breast Cancer: Molecular Testing, Treatment Selection and Sequencing 2027: Istanbul

Hosted by European Society for Medical Oncology

Let others know you'll be there. This does not register you for the event.

Welcome to kongre.net
Welcome to kongre.net

Key facts

ESMO Advanced Course on HR+/HER2- Metastatic Breast Cancer: Molecular Testing, Treatment Selection and Sequencing 2027: Istanbul is a course held 10 – 11 January 2027 in Istanbul, Türkiye, organised by European Society for Medical Oncology.

Dates:
10 – 11 January 2027
Format:
In person
Venue:
Istanbul, Türkiye
Subjects:
Oncology & Cancer Research, Medical & Health Sciences
The ESMO Advanced Course on HR+/HER2- Metastatic Breast Cancer focuses on molecular testing, treatment selection, and sequencing strategies.

Conference theme

HR+/HER2- Metastatic Breast Cancer: Molecular Testing, Treatment Selection and Sequencing

Objectives

Evaluate clinical evidence supporting the use of targeted agents, endocrine therapy and antibody-drug conjugates in HR+/HER2 metastatic breast cancer. Recognise mechanisms of resistance and strategies to overcome them and to outline treatment sequencing. Assess the safety, toxicity, and quality of life implications of novel agents in HR+/HER2- metastatic breast cancer. Explore future directions in drug development.

Organising Committee

Giuseppe Curigliano - Chair, University of Milan and European Institute of Oncology, IRCCS Milan, Italy Petra Tesarova - Chair, Prague, Czech Republic
Venue & travel Istanbul, TürkiyeVenue detailsAbout the organiser European Society for Medical Oncology4 more events from this organiserOrganiser profileWho is going? See who is planning to attend and say you are goingSee who is going

Organiser and contact

Advertisement

Related events